?>
Plan Name | INNOVATIVE BLOOD RESOURCES 401(K) PLAN |
Plan identification number | 008 |
401k Plan Type | Defined Contribution Pension |
Plan Features/Benefits |
|
Company Name: | NEW YORK BLOOD CENTER, INC. |
Employer identification number (EIN): | 131949477 |
NAIC Classification: | 621900 |
Additional information about NEW YORK BLOOD CENTER, INC.
Jurisdiction of Incorporation: | New York Department of State |
Incorporation Date: | 1959-04-13 |
Company Identification Number: | 118798 |
Legal Registered Office Address: |
310 E. 67TH STREET New York NEW YORK United States of America (USA) 10065 |
More information about NEW YORK BLOOD CENTER, INC.
Plan id# | Filing Submission Date | Name of Administrator | Date Administrator Signed | Name of Company Sponsor | Date Sponsor Signed |
---|---|---|---|---|---|
008 | 2021-01-01 | ||||
008 | 2020-01-01 |
Measure | Date | Value |
---|---|---|
2021: INNOVATIVE BLOOD RESOURCES 401(K) PLAN 2021 401k membership | ||
Total participants, beginning-of-year | 2021-01-01 | 661 |
Total number of active participants reported on line 7a of the Form 5500 | 2021-01-01 | 0 |
Number of retired or separated participants receiving benefits | 2021-01-01 | 0 |
Number of other retired or separated participants entitled to future benefits | 2021-01-01 | 0 |
Total of all active and inactive participants | 2021-01-01 | 0 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2021-01-01 | 0 |
Total participants | 2021-01-01 | 0 |
Number of participants with account balances | 2021-01-01 | 0 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2021-01-01 | 0 |
2020: INNOVATIVE BLOOD RESOURCES 401(K) PLAN 2020 401k membership | ||
Total participants, beginning-of-year | 2020-01-01 | 651 |
Total number of active participants reported on line 7a of the Form 5500 | 2020-01-01 | 396 |
Number of retired or separated participants receiving benefits | 2020-01-01 | 0 |
Number of other retired or separated participants entitled to future benefits | 2020-01-01 | 145 |
Total of all active and inactive participants | 2020-01-01 | 541 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2020-01-01 | 9 |
Total participants | 2020-01-01 | 550 |
Number of participants with account balances | 2020-01-01 | 535 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2020-01-01 | 21 |
Measure | Date | Value |
---|---|---|
2021 : INNOVATIVE BLOOD RESOURCES 401(K) PLAN 2021 401k financial data | ||
Total unrealized appreciation/depreciation of assets | 2021-11-17 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2021-11-17 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2021-11-17 | $0 |
Total income from all sources (including contributions) | 2021-11-17 | $2,489,042 |
Total loss/gain on sale of assets | 2021-11-17 | $0 |
Total of all expenses incurred | 2021-11-17 | $26,617,711 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2021-11-17 | $26,526,766 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2021-11-17 | $119 |
Value of total assets at end of year | 2021-11-17 | $0 |
Value of total assets at beginning of year | 2021-11-17 | $24,128,669 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2021-11-17 | $90,945 |
Total interest from all sources | 2021-11-17 | $8,160 |
Total dividends received (eg from common stock, registered investment company shares) | 2021-11-17 | $6,843 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2021-11-17 | Yes |
Value of any plan assets that reverted to the employer resulting from resoluton to terminate the plan | 2021-11-17 | $0 |
Total dividends received from registered investment company shares (eg mutual funds) | 2021-11-17 | $6,843 |
Was this plan covered by a fidelity bond | 2021-11-17 | Yes |
Value of fidelity bond cover | 2021-11-17 | $500,000 |
If this is an individual account plan, was there a blackout period | 2021-11-17 | Yes |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2021-11-17 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2021-11-17 | No |
Participant contributions at beginning of year | 2021-11-17 | $310,754 |
Other income not declared elsewhere | 2021-11-17 | $-5,045 |
Administrative expenses (other) incurred | 2021-11-17 | $36,317 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2021-11-17 | No |
Value of net income/loss | 2021-11-17 | $-24,128,669 |
Value of net assets at end of year (total assets less liabilities) | 2021-11-17 | $0 |
Value of net assets at beginning of year (total assets less liabilities) | 2021-11-17 | $24,128,669 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2021-11-17 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2021-11-17 | No |
Were any leases to which the plan was party in default or uncollectible | 2021-11-17 | No |
Investment advisory and management fees | 2021-11-17 | $9,368 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2021-11-17 | $15,809,937 |
Interest on participant loans | 2021-11-17 | $8,160 |
Value of interest in common/collective trusts at beginning of year | 2021-11-17 | $8,006,899 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2021-11-17 | $1,563,769 |
Net investment gain or loss from common/collective trusts | 2021-11-17 | $915,196 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2021-11-17 | No |
Was there a failure to transmit to the plan any participant contributions | 2021-11-17 | No |
Has the plan failed to provide any benefit when due under the plan | 2021-11-17 | No |
Contributions received in cash from employer | 2021-11-17 | $119 |
Employer contributions (assets) at beginning of year | 2021-11-17 | $1,079 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2021-11-17 | $26,526,766 |
Contract administrator fees | 2021-11-17 | $45,260 |
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2021-11-17 | Yes |
Did the plan have assets held for investment | 2021-11-17 | No |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2021-11-17 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2021-11-17 | Yes |
Opinion of an independent qualified public accountant for this plan | 2021-11-17 | Disclaimer |
Accountancy firm name | 2021-11-17 | CLIFTONLARSONALLEN LLP |
Accountancy firm EIN | 2021-11-17 | 410746749 |
2020 : INNOVATIVE BLOOD RESOURCES 401(K) PLAN 2020 401k financial data | ||
Unrealized appreciation/depreciation of real estate assets | 2020-12-31 | $0 |
Unrealized appreciation/depreciation of other (non real estate) assets | 2020-12-31 | $0 |
Total unrealized appreciation/depreciation of assets | 2020-12-31 | $0 |
Total transfer of assets to this plan | 2020-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2020-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2020-12-31 | $0 |
Expenses. Interest paid | 2020-12-31 | $0 |
Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102 | 2020-12-31 | $0 |
Total income from all sources (including contributions) | 2020-12-31 | $5,388,915 |
Total loss/gain on sale of assets | 2020-12-31 | $0 |
Total of all expenses incurred | 2020-12-31 | $2,500,262 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2020-12-31 | $2,381,464 |
Expenses. Certain deemed distributions of participant loans | 2020-12-31 | $1,105 |
Value of total corrective distributions | 2020-12-31 | $3,156 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2020-12-31 | $1,933,816 |
Value of total assets at end of year | 2020-12-31 | $24,128,669 |
Value of total assets at beginning of year | 2020-12-31 | $21,240,016 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2020-12-31 | $114,537 |
Total income from rents | 2020-12-31 | $0 |
Total interest from all sources | 2020-12-31 | $17,467 |
Total dividends received (eg from common stock, registered investment company shares) | 2020-12-31 | $185,814 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2020-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2020-12-31 | $185,814 |
Administrative expenses professional fees incurred | 2020-12-31 | $0 |
Was this plan covered by a fidelity bond | 2020-12-31 | Yes |
Value of fidelity bond cover | 2020-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2020-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2020-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2020-12-31 | No |
Amount of non-exempt transactions with any party-in-interest | 2020-12-31 | $0 |
Contributions received from participants | 2020-12-31 | $1,261,175 |
Participant contributions at end of year | 2020-12-31 | $310,754 |
Participant contributions at beginning of year | 2020-12-31 | $379,058 |
Participant contributions at end of year | 2020-12-31 | $0 |
Participant contributions at beginning of year | 2020-12-31 | $0 |
Income. Received or receivable in cash from other sources (including rollovers) | 2020-12-31 | $24,054 |
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries) | 2020-12-31 | $0 |
Value of other receiveables (less allowance for doubtful accounts) at end of year | 2020-12-31 | $0 |
Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2020-12-31 | $0 |
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2020-12-31 | $0 |
Other income not declared elsewhere | 2020-12-31 | $471 |
Administrative expenses (other) incurred | 2020-12-31 | $114,537 |
Liabilities. Value of operating payables at beginning of year | 2020-12-31 | $0 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2020-12-31 | No |
Income. Non cash contributions | 2020-12-31 | $0 |
Value of net income/loss | 2020-12-31 | $2,888,653 |
Value of net assets at end of year (total assets less liabilities) | 2020-12-31 | $24,128,669 |
Value of net assets at beginning of year (total assets less liabilities) | 2020-12-31 | $21,240,016 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2020-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2020-12-31 | No |
Amount of loans by the plan or fixed income obligations due to the plan which were in default/classified-as-uncollectible as of the close of the plan year | 2020-12-31 | $0 |
Were any leases to which the plan was party in default or uncollectible | 2020-12-31 | No |
Amount of leases to which the plan was a party which were in default/classified-as-uncollectible during the year | 2020-12-31 | $0 |
Investment advisory and management fees | 2020-12-31 | $0 |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2020-12-31 | $15,809,937 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2020-12-31 | $13,339,024 |
Interest on participant loans | 2020-12-31 | $17,467 |
Income. Interest from loans (other than to participants) | 2020-12-31 | $0 |
Interest earned on other investments | 2020-12-31 | $0 |
Income. Interest from US Government securities | 2020-12-31 | $0 |
Income. Interest from corporate debt instruments | 2020-12-31 | $0 |
Value of interest in common/collective trusts at end of year | 2020-12-31 | $8,006,899 |
Value of interest in common/collective trusts at beginning of year | 2020-12-31 | $7,521,934 |
Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2020-12-31 | $0 |
Expenses. Payments to insurance carriers foe the provision of benefits | 2020-12-31 | $0 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2020-12-31 | $2,438,905 |
Net investment gain/loss from pooled separate accounts | 2020-12-31 | $0 |
Net investment gain or loss from common/collective trusts | 2020-12-31 | $812,442 |
Net gain/loss from 103.12 investment entities | 2020-12-31 | $0 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2020-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2020-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2020-12-31 | No |
Contributions received in cash from employer | 2020-12-31 | $648,587 |
Employer contributions (assets) at end of year | 2020-12-31 | $1,079 |
Employer contributions (assets) at beginning of year | 2020-12-31 | $0 |
Income. Dividends from preferred stock | 2020-12-31 | $0 |
Income. Dividends from common stock | 2020-12-31 | $0 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2020-12-31 | $2,381,464 |
Contract administrator fees | 2020-12-31 | $0 |
Liabilities. Value of benefit claims payable at beginning of year | 2020-12-31 | $0 |
Did the plan have assets held for investment | 2020-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2020-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2020-12-31 | No |
Aggregate proceeds on sale of assets | 2020-12-31 | $0 |
Aggregate carrying amount (costs) on sale of assets | 2020-12-31 | $0 |
Liabilities. Value of acquisition indebtedness at beginning of year | 2020-12-31 | $0 |
Opinion of an independent qualified public accountant for this plan | 2020-12-31 | Disclaimer |
Accountancy firm name | 2020-12-31 | CLIFTONLARSONALLEN LLP |
Accountancy firm EIN | 2020-12-31 | 410746749 |
2021: INNOVATIVE BLOOD RESOURCES 401(K) PLAN 2021 form 5500 responses | ||
---|---|---|
2021-01-01 | Type of plan entity | Single employer plan |
2021-01-01 | This submission is the final filing | Yes |
2021-01-01 | This return/report is a short plan year return/report (less than 12 months) | Yes |
2021-01-01 | Plan is a collectively bargained plan | No |
2021-01-01 | Plan funding arrangement – Trust | Yes |
2021-01-01 | Plan benefit arrangement - Trust | Yes |
2020: INNOVATIVE BLOOD RESOURCES 401(K) PLAN 2020 form 5500 responses | ||
2020-01-01 | Type of plan entity | Single employer plan |
2020-01-01 | This submission is the final filing | No |
2020-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2020-01-01 | Plan is a collectively bargained plan | No |
2020-01-01 | Plan funding arrangement – Trust | Yes |
2020-01-01 | Plan benefit arrangement - Trust | Yes |